Look up a license
Match the name or license number. Check status, expiration, and any restrictions shown.
LICENSEE SEARCH Covers: Missouri Board of Pharmacy.Missouri Board of Pharmacy
Missouri Pharmacy CE Requirements
Missouri pharmacists need 30 hours of continuing education every 2 years.
Need your license record? Jump to lookup, verification & renewal ↓Free CE courses ↓Exam preparation ↓
At a glance
Missouri pharmacy license renewal
| Licenses covered | Pharmacist (RPh) [1] |
|---|---|
| CE required for renewal | Yes [1] |
| Hours per CE period | 30 hours [1] |
| CE period | Every 2 years [1] |
| Renewal and reporting | Pharmacist licenses renew biennially; continuing education hours earned after October 31 of even-numbered years apply to the next reporting period. [1] |
| State-mandated topics | Check the board’s full topic requirements |
| What CE counts | Continuing pharmacy education programs approved by ACPE are accepted as approved continuing education courses for license renewal without prior individual submission to the Board. [1] |
This summary covers the licenses listed above. The topics below are selected verified requirements; consult the board’s full rules for all subjects and conditions.
Good to know
- Pharmacists first licensed by the Board within 12 months immediately preceding the October 31 biennial renewal date are exempt from CE requirements for that reporting period. [1]
Rules change, and your own license record decides your deadline. Confirm with the Missouri Board of Pharmacy ↗ before you renew.
Your next step
Look up. Verify. Renew.
Verify a credential
A public search may be enough for a status check. Another board or employer may require a verification sent directly by the issuer.
Check verification instructions Confirm the recipient’s required format and any fee.Renew your license
Confirm your due date, complete the required education, and submit to the licensing authority.
RENEW A LICENSE Covers: Missouri Board of Pharmacy.Renewal at a glance
| Credential | Pharmacist |
|---|---|
| Renewal cycle | Confirm the cycle and expiration date for your specific license with the board. |
| Verified fees | A current fee has not been confirmed in this guide. Check the board’s fee schedule before paying. |
| Renewal application | RENEW A LICENSE |
Fees can differ for active, inactive, late, and reinstatement applications. Your official license record controls your deadline.
Source review dates · 2 sources
Dates show when we retrieved the source pages. They do not certify a person’s license, guarantee a portal is online, or establish that every renewal rule was reviewed.
- Board of Pharmacy | Contact Your Board | NABP Retrieved Oct 13, 2026
- Board of Pharmacy2025 MOPRO - How to Register - YouTube Retrieved Oct 13, 2026
Free courses that count toward the hours
Free CE accepted in Missouri
The board accepts continuing education accredited by ACPE [1]. These current free courses state that accreditation. State-mandated topics can require a specific approved course, so check those separately.
Academy for Continued Healthcare LearningFree
Available on demandStrategies for Improving ERBB2 (HER2) Testing in NSCLC Within Community Settings
The pace at which targetable tumor-specific molecular alterations have been identified over the past decade have ushered in an era of precision oncology, yielding significant insights into the diversity of cancer, offering diagnostic and prognostic benefits, and guiding therapy selection. Indeed, guidelines emphasize that comprehensive biomarker testing should be conducted to identify actionable mutations in non-small-cell lung cancer (NSCLC), including ALK, EGFR, KRAS, MET, RET, and ERBB2 (HER2). These tests guide the selection of targeted therapies that can inhibit oncogenic pathways directl
Checked Oct 20, 2026
Academy for Continued Healthcare LearningFree
Available on demandIntegrating Clinical Pharmacists Into Collaborative Care For Patients With T2D To Realize Early Benefits of Once-Weekly Insulin Regimens
The management of type 2 diabetes (T2D) is complex, requiring a multidisciplinary, patient-centered approach that accounts for individualized glycemic and weight goals, comorbidities, hypoglycemia risk, medication costs, and individual preferences. Therapeutic inertia and patient reluctance often delay insulin initiation and intensification in patients with persistent hyperglycemia despite multiple antihyperglycemic agents. The emergence of once-weekly basal insulin analogues represent a transformative advancement in T2D management, offering a simplified treatment paradigm to address common ba
Checked Oct 20, 2026
Academy for Continued Healthcare LearningFree
Available on demandNavigating Complexity in the Post-CDK4/6 Inhibitor Treatment Setting for Patients With ER+/HER2- mBC: Strategies for Optimally Integrating Next-Generation Oral SERDs
The management of hormone receptor–positive (HR-positive), human epidermal growth factor receptor 2–negative (HER2-negative) metastatic breast cancer (mBC) is undergoing rapid transformation, largely driven by the imperative to overcome acquired endocrine resistance, frequently mediated by somatic estrogen receptor 1 (ESR1) mutations. These mutations predict a lack of benefit from further aromatase inhibitor (AI) therapy, making the correct identification and subsequent targeting of these alterations critical for guiding treatment selection. Next-generation oral selective estrogen receptor deg
Checked Oct 20, 2026
Academy for Continued Healthcare LearningFree
Available on demandSupporting Real-World Achievement of Treat-to-Target in IBD: Scalable Strategies for Integrating Objective Markers of Inflammation and Patient-Reported Monitoring in Routine Clinical Practice
Selecting, intensifying, sequencing, or combining therapies in IBD can be challenging for clinicians, especially considering the number of novel targeted therapies available and the expanding role of patient-reported outcomes in individualization of therapeutic decision-making. Advance your IBD management through implementation of recommended treat-to-target strategies. Start with an individualized assessment to determine the strengths and gaps in your current practice, then review educational content according to your needs. Reinforce your learning through practical guidance (eg, interactive
Checked Oct 20, 2026
FreeCME.comFree
Available on demandImproving Outcomes in Treatment-Resistant Depression Through…
a statement of participation Target Audience The intended audience for this activity is physicians and nurse practitioners specializing in psychiatry as well as pharmacists who are involved in the management of patients with treatment-resistant depression (TRD). Program Overview Treatment-resistant depression (TRD) presents ongoing challenges for psychiatric clinicians, including delayed recognition, trial-and-error treatment sequencing, and high relapse rates
Checked Oct 20, 2026
FreeCME.comFree
Available on demandPsychedelics in Anxiety and Depression: A Practical Update
a statement of participation. Target Audience The intended audience for this activity is physicians and nurse practitioners specializing in psychiatry, as well as pharmacists who are involved in the management of patients with anxiety and/or depression. Program Overview Several psychedelic and psychedelic-adjacent therapies are advancing through late-stage clinical development, expanding the evidence base supporting their efficacy in the management of anxiety a
Checked Oct 20, 2026
NetCEFree
Available on demandHealth 2.0: Implications for Care
Health 2.0: Implications for Care. A no-cost NetCE course from the reviewed profession catalog free sections.
Checked Oct 20, 2026
Pharmacy Times Continuing EducationFree
Available on demand2025 SABCS Abstracts to Action: From Data to Decisions in HR+ Breast Cancer Care
2025 SABCS Abstracts to Action: From Data to Decisions in HR+ Breast Cancer Care. A continuing education activity offered by Pharmacy Times Continuing Education.
Checked Oct 20, 2026
Pharmacy Times Continuing EducationFree
Available on demandA Managed Care Perspective on Hard-to-Control Hypertension: Understanding the Risks and Challenges in Uncontrolled and Resistant Hypertension
A Managed Care Perspective on Hard-to-Control Hypertension: Understanding the Risks and Challenges in Uncontrolled and Resistant Hypertension. A continuing education activity offered by Pharmacy Times Continuing Education.
Checked Oct 20, 2026
Your next credential
Free exam preparation for pharmacists
Explore Missouri and national exam practice for your profession on OpenExamPrep.
OpenExamPrepFree exam preparation Free practice
More exam preparation for pharmacists →Missouri MPJE Pharmacy Jurisprudence
Free practiceNABP NAPLEX North American Pharmacist Licensure Examination
These are exam-preparation resources, separate from continuing education credit. Exam registration fees and eligibility are set by the exam sponsor.
Questions
Missouri pharmacy CE, answered
How many CE hours do Missouri pharmacists need?
Missouri pharmacists need 30 hours of continuing education every 2 years. Pharmacist licenses renew biennially; continuing education hours earned after October 31 of even-numbered years apply to the next reporting period.
Does Missouri require specific CE topics for pharmacists?
A complete topic list is not verified in this guide. Check the Missouri Board of Pharmacy for mandated subjects, live instruction and other conditions for your credential.
Do free online CE courses count in Missouri?
Continuing pharmacy education programs approved by ACPE are accepted as approved continuing education courses for license renewal without prior individual submission to the Board. Free courses accredited by ACPE are listed on this page; a state-mandated topic may need a specific approved course.
Sources & verification
Every fact above links to the official page it comes from. We fetched each page on the date shown and confirmed the exact wording below appears on it.
- 20c2220-7 ↗www.sos.mo.gov · PDF · Retrieved Oct 28, 2026
Quoted wording (7)
“(2) Required Hours. As a condition of renewal, all active Missouri pharmacist licensees shall complete thirty (30) hours of continuing education during the two (2) year continuing education reporting period preceding renewal of the license. For purposes of this rule, the reporting period is the twenty-four- (24-) month period beginning on November 1 of even-numbered”
“(2) Required Hours. As a condition of renewal, all active Missouri pharmacist licensees shall complete thirty (30) hours of continuing education during the two (2) year continuing education reporting period preceding renewal of the license. For purposes of this rule, the reporting period is the twenty-four- (24-) month period beginning on November 1 of even-numbered”
“(2) Required Hours. As a condition of renewal, all active Missouri pharmacist licensees shall complete thirty (30) hours of continuing education during the two (2) year continuing education reporting period preceding renewal of the license. For purposes of this rule, the reporting period is the twenty-four- (24-) month period beginning on November 1 of even-numbered”
“(2) Required Hours. As a condition of renewal, all active Missouri pharmacist licensees shall complete thirty (30) hours of continuing education during the two (2) year continuing education reporting period preceding renewal of the license. For purposes of this rule, the reporting period is the twenty-four- (24-) month period beginning on November 1 of even-numbered”
“ending on October 31 of even-numbered years. Continuing education hours earned after October 31 of even-numbered years shall apply to the next continuing education period. (A) A pharmacist first licensed by the board within twelve (12) months immediately preceding the October 31 biennial renewal date shall be exempt from the continuing”
“INSURANCE DIVISION 2220—STATE BOARD OF PHARMACY by ACPE shall be accepted as approved continuing education courses for purposes of license renewal and are not required to be individually submitted to the board for prior approval. (D) The board shall not grant continuing education credit for any course that”
“to the next continuing education period. (A) A pharmacist first licensed by the board within twelve (12) months immediately preceding the October 31 biennial renewal date shall be exempt from the continuing pharmacy education requirements for that reporting period. (B) Hours obtained in excess of the thirty (30) hours required by this rule may not”